Delisting Far From Overwhelming — One Shareholder, One Outcome
Headlines stating that shareholders "overwhelmingly" backed Pact Group’s delisting from the ASX fail to tell the real story. Yes, 90.73% of the vote was in favour. But what those headlines ignore is that one shareholder Raphael Geminder controls nearly 88% of the stock and used that control to force the outcome. The remaining entire body of minority shareholders representing thousands of investorsoverwhelmingly opposed the delisting.
This wasn't a genuine democratic vote. It was a foregone conclusion engineered by a dominant shareholder with the power to push through a decision that benefits himself while disenfranchising everyone else.
The vote tally tells a different story when viewed properly:
Raphael Geminder voted yes with 88% of the shares.
Nearly all other shareholders — the remaining 12% — voted NO!
To call this "overwhelming shareholder support" is not just misleading it's insulting to the small investors who supported the company over the years, only to be locked into a private structure with no liquidity, no transparency, and no recourse.
Delisting without a share buyback or any form of liquidity facility effectively traps these shareholders in a company that no longer has public oversight. It strips away the protections of ASX listing rules, continuous disclosure obligations, and market-based valuation all while handing Geminder total control behind closed doors.
This vote wasn’t about shareholder democracy it was about shareholder dominance. And it sends a chilling message to retail investors in Australia: if you’re not in control, your voice doesn’t mattter!
Minority shareholders deserve better than being used as window dressing in a process designed to appear fair. The truth is, this wasn’t a landslide but a foregone conclusion.
- Forums
- ASX - By Stock
- PGH
- What Now
PGH
pact group holdings ltd
Add to My Watchlist
1.27%
!
78.0¢

What Now, page-31
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
78.0¢ |
Change
-0.010(1.27%) |
Mkt cap ! $268.5M |
Open | High | Low | Value | Volume |
77.0¢ | 79.5¢ | 77.0¢ | $9.397K | 12.07K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5624 | 78.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
79.5¢ | 3586 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5624 | 0.780 |
1 | 12500 | 0.755 |
2 | 13977 | 0.750 |
1 | 13396 | 0.745 |
1 | 7000 | 0.740 |
Price($) | Vol. | No. |
---|---|---|
0.800 | 13124 | 2 |
0.820 | 2965 | 1 |
0.830 | 20539 | 1 |
0.850 | 99 | 1 |
0.870 | 8620 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
PGH (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online